Medtronic plc Stockholders Equity

Quick Answer

Medtronic plc reported Stockholders Equity of $48.02 billion for fiscal year 2025.

Medtronic plc Stockholders Equity — Annual History

Fiscal Year Stockholders Equity YoY Change
2025 $48.02B -4.4%
2024 $50.21B -2.5%
2023 $51.48B -2.0%
2022 $52.55B +2.2%
2021 $51.43B +1.4%
2020 $50.74B +1.3%
2019 $50.09B -1.2%
2018 $50.72B +1.0%
2017 $50.21B -3.6%
2016 $52.06B -2.2%
2015 $53.23B +173.8%
2014 $19.44B +4.1%
2013 $18.67B +9.1%
2012 $17.11B

Quarterly Stockholders Equity

Quarter Ending Stockholders Equity YoY QoQ
January 31, 2026 $48.98B -0.8% +0.7%
October 31, 2025 $48.65B +0.3% +1.6%
July 31, 2025 $47.89B -0.1% -0.3%
April 30, 2025 $48.02B -4.4% -2.8%
January 31, 2025 $49.39B -4.6% +1.8%
October 31, 2024 $48.49B -5.8% +1.1%
July 31, 2024 $47.95B -6.3% -4.5%
April 30, 2024 $50.21B -2.5% -3.0%
  • Medtronic plc showed a decrease of -4.4% in Stockholders Equity compared to the prior fiscal year.
  • Over the 2012–2025 period, Medtronic plc’s stockholders equity has grown by 180.6% (from $17.11 billion to $48.02 billion).
  • The most recent figure is from Medtronic plc’s fiscal year 2025 report (Form 10-K), filed with the SEC on June 20, 2025.
  • All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.

Last verified:

Leave a Comment